Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Alaj R"'
Autor:
Robertson E; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Naghavi N; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Wipperman MF; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Tuckwell K; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Effendi M; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Alaj R; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Urbanek J; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Lederer D; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Fredenburgh L; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Stuart S; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.; Department of Sport, Exercise and Rehabilitation, Northumbria University, Newcastle upon Tyne, UK.; Department of Neurology, Oregon Health & Science University, Portland, OR, USA.
Publikováno v:
Digital health [Digit Health] 2024 Sep 11; Vol. 10, pp. 20552076241277174. Date of Electronic Publication: 2024 Sep 11 (Print Publication: 2024).
Autor:
Wipperman MF; Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States.; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Lin AZ; Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Gayvert KM; Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Lahner B; Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States.; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States.; Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Somersan-Karakaya S; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Wu X; Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Im J; Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Lee M; Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Koyani B; Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Setliff I; Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Thakur M; Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Duan D; Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States.; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Breazna A; Biostatistics and Data Management, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Wang F; Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States.; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Lim WK; Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Halasz G; Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Urbanek J; Biostatistics and Data Management, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Patel Y; General Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Atwal GS; Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Hamilton JD; Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States.; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Stuart S; Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Levy O; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Avbersek A; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Alaj R; Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Hamon SC; Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States.; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Harari O; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States.
Publikováno v:
ELife [Elife] 2024 Apr 30; Vol. 13. Date of Electronic Publication: 2024 Apr 30.
Autor:
Bertha A; Bayer, 801 Pennsylvania Ave NW, Washington, DC, 20004, USA. amy.bertha@bayer.com., Alaj R; Regeneron, Terrytown, NJ, USA., Bousnina I; Genentech, South San Francisco, CA, USA., Doyle MK; Amgen, Thousand Oaks, CA, USA., Friend D; Janssen, Raritan, NJ, USA., Kalamegham R; Genentech, South San Francisco, CA, USA., Oliva L; Biogen, Cambridge, MA, USA., Knezevic I; Bayer, Wuppertal, Germany., Kramer F; Bayer, Wuppertal, Germany., Podhaisky HP; Bayer, Berlin, Germany., Reimann S; Bayer, Wuppertal, Germany.
Publikováno v:
NPJ digital medicine [NPJ Digit Med] 2023 Aug 10; Vol. 6 (1), pp. 139. Date of Electronic Publication: 2023 Aug 10.
Autor:
Wipperman MF; Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America.; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America., Pogoncheff G; Earable Inc., Boulder, Colorado, United States of America., Mateo KF; Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America., Wu X; Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America., Chen Y; Biostatistics and Data Management, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America., Levy O; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America., Avbersek A; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America., Deterding RR; Earable Inc., Boulder, Colorado, United States of America., Hamon SC; Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America.; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America., Vu T; Earable Inc., Boulder, Colorado, United States of America., Alaj R; Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America., Harari O; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America.
Publikováno v:
PLOS digital health [PLOS Digit Health] 2022 Jun 30; Vol. 1 (6), pp. e0000061. Date of Electronic Publication: 2022 Jun 30 (Print Publication: 2022).
Autor:
Crouthamel M; Digital Health & Innovation, Global Clinical Development, AbbVie Inc., North Chicago, Illinois, USA., Mather RJ; Early Clinical Development, Pfizer Inc., Cambridge, Massachusetts, USA., Ramachandran S; Global Regulatory Affairs and Clinical Safety (SR), MRL (KB), Merck & Co, Inc., Kenilworth, New Jersey, USA., Bode K; Global Regulatory Affairs and Clinical Safety (SR), MRL (KB), Merck & Co, Inc., Kenilworth, New Jersey, USA., Chatterjee G; Clinical Study Unit (India-South East Asia Cluster), Sanofi Healthcare India Private Limited, Mumbai, India., Garcia-Gancedo L; Value Evidence and Outcomes, GSK, Stevenage, United Kingdom., Kim J; Translational Technology and Innovation, Office of Digital Health, Eli Lilly and Company, Indianapolis, Indiana, USA., Alaj R; Clinical Outcomes Assessment and Patient Innovation, Global Study Strategy & Optimization (RA), Precision Medicine, Early Clinical Development & Experimental Sciences (MFW), Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Wipperman MF; Clinical Outcomes Assessment and Patient Innovation, Global Study Strategy & Optimization (RA), Precision Medicine, Early Clinical Development & Experimental Sciences (MFW), Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Leyens L; Product Development Regulatory, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Sillen H; Digital Health R&D, AstraZeneca, Mölndal, Sweden., Murphy T; Regulatory Affairs Innovation, Novartis Pharmaceuticals, East Hanover, New Jersey, USA., Benecky M; Global Regulatory Affairs, UCB Biosciences, Inc., Raleigh, North Carolina, USA., Maggio B; Digital Trials - Global Clinical Operations, Boehringer-Ingelheim, Ridgefield, Connecticut, USA., Switzer T; Early Clinical Development Informatics, Genentech, South San Francisco, California, USA.
Publikováno v:
Digital biomarkers [Digit Biomark] 2021 Sep 02; Vol. 5 (3), pp. 191-205. Date of Electronic Publication: 2021 Sep 02 (Print Publication: 2021).
Autor:
Daci A; Department of Pharmacy, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo.; Institute of Pharmacology and Toxicology, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo., Da Dalt L; Department of Excellence of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy., Alaj R; Cardiovascular Surgery Clinic, University Clinical Center of Kosovo, Prishtina, Kosovo., Shurdhiqi S; Cardiovascular Surgery Clinic, University Clinical Center of Kosovo, Prishtina, Kosovo., Neziri B; Institute of Pathophysiology, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo., Ferizi R; Department of Premedical Courses-Biology, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo., Danilo Norata G; Department of Excellence of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy.; Centro SISA per lo Studio dell'Aterosclerosi, Ospedale Bassini, Cinisello Balsamo, Italy., Krasniqi S; Institute of Pharmacology and Toxicology, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo.
Publikováno v:
PloS one [PLoS One] 2020 Dec 10; Vol. 15 (12), pp. e0240669. Date of Electronic Publication: 2020 Dec 10 (Print Publication: 2020).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jannati, Shirin1 (AUTHOR) shirin.jannati@students.mbru.ac.ae, Patnaik, Rajashree1 (AUTHOR) rajashree.patnaik@mbru.ac.ae, Banerjee, Yajnavalka1,2 (AUTHOR) yajnavalka.banerjee@mbru.ac.ae
Publikováno v:
International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 16, p8727. 87p.
Autor:
Daci A; Department of Pharmacy, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo., Bozalija A; Department of Pharmacy, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo., Cavolli R; Cardiovascular Surgery Clinic, University Clinical Center of Kosovo, Prishtina, Kosovo., Alaj R; Cardiovascular Surgery Clinic, University Clinical Center of Kosovo, Prishtina, Kosovo., Beretta G; Department of Pharmaceutical Sciences, Università degli Studi di Milano, Milan, Italy., Krasniqi S; Department of Pharmacology, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo.
Publikováno v:
Open access Macedonian journal of medical sciences [Open Access Maced J Med Sci] 2018 Mar 12; Vol. 6 (3), pp. 498-505. Date of Electronic Publication: 2018 Mar 12 (Print Publication: 2018).
Autor:
Daci A; Department of Pharmacy, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo; Institute of Pharmacology and Toxicology, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo., Neziri B; Institute of Pathophysiology, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo., Krasniqi S; Institute of Pharmacology and Toxicology, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo. Electronic address: shaip.krasniqi@uni-pr.edu., Cavolli R; Cardiovascular Surgery Clinic, University Clinical Center of Kosovo, Prishtina, Kosovo., Alaj R; Cardiovascular Surgery Clinic, University Clinical Center of Kosovo, Prishtina, Kosovo., Norata GD; Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy; School of Biomedical Sciences, Curtin Health Innovation Research Institute, Faculty of Health Science, Curtin University, Perth, Western Australia, Australia., Beretta G; Department of Environmental Science and Policy, Università degli Studi di Milano, Milan, Italy.
Publikováno v:
European journal of pharmacology [Eur J Pharmacol] 2017 Sep 05; Vol. 810, pp. 51-56. Date of Electronic Publication: 2017 Jun 08.